96 related articles for article (PubMed ID: 1093294)
41. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
42. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
Mazureka C; Stiffel C; Chalvet H; Biozzi G
C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
[TBL] [Abstract][Full Text] [Related]
43. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
Likhite VV; Halpern BN
Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
[No Abstract] [Full Text] [Related]
44. A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.
McBride WH; Dawes J; Dunbar N; Ghaffar A; Woodruff MF
Immunology; 1975 Jan; 28(1):49-58. PubMed ID: 1116870
[TBL] [Abstract][Full Text] [Related]
45. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
[TBL] [Abstract][Full Text] [Related]
46. [Antimetastatic properties of aloe juice].
Gribel' NV; Pashinskiĭ VG
Vopr Onkol; 1986; 32(12):38-40. PubMed ID: 3798837
[TBL] [Abstract][Full Text] [Related]
47. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
[TBL] [Abstract][Full Text] [Related]
48. Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma.
Yuhas JM; Toya RE; Wagner E
Cancer Res; 1975 Jan; 35(1):242-4. PubMed ID: 1109793
[TBL] [Abstract][Full Text] [Related]
49. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
50. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
Miyata H
Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
[No Abstract] [Full Text] [Related]
51. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
[TBL] [Abstract][Full Text] [Related]
52. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
Milas L; Hersh EM; Hunter N
Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
[TBL] [Abstract][Full Text] [Related]
53. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
Hengst JC; Mokyr MB; Dray S
Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
[No Abstract] [Full Text] [Related]
54. Neuraminidase treated cells and their role in cancer immunotherapy.
Simmons RL; Rios A
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
[No Abstract] [Full Text] [Related]
55. Recent therapeutic developments in lung cancer.
Hansen HH; Selawry OS
Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
[No Abstract] [Full Text] [Related]
56. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
57. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
Savary CA; Lotzová E
J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
[TBL] [Abstract][Full Text] [Related]
58. Letter: Anaerobic corynebacteria and anaesthetics.
Milas L
Lancet; 1975 Mar; 1(7908):695-6. PubMed ID: 47129
[No Abstract] [Full Text] [Related]
59. [Experimental studies on the antitumor activity of corynebacterium liquefaciens].
Nakagawa H; Kato A; Fukita H; Sakurai H; Kasahara H
Tsurumi Shigaku; 1977 Jun; 3(1):19-27. PubMed ID: 276194
[No Abstract] [Full Text] [Related]
60. Effect of aerobic and anaerobic corynebacteria on reaginic antibody response in mice.
Adachi H; Yabu-Uchi K; Ozawa K; Sindo T; Tadokoro I
Microbiol Immunol; 1978; 22(1):53-6. PubMed ID: 661628
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
